Invention Grant
- Patent Title: Modified tuberculosis antigens
- Patent Title (中): 改良型结核杆菌抗原
-
Application No.: US13574816Application Date: 2011-01-27
-
Publication No.: US08932600B2Publication Date: 2015-01-13
- Inventor: Normand Blais , James Brown , Anne-Marie Gelinas , Pascal Mettens , Dennis Murphy
- Applicant: Normand Blais , James Brown , Anne-Marie Gelinas , Pascal Mettens , Dennis Murphy
- Applicant Address: BE Rixensart GB Greenford, Middlesex
- Assignee: GlaxoSmithKline Biologicals S.A.,Glaxo Group Limited
- Current Assignee: GlaxoSmithKline Biologicals S.A.,Glaxo Group Limited
- Current Assignee Address: BE Rixensart GB Greenford, Middlesex
- Agent Eric J. Kron
- International Application: PCT/EP2011/051158 WO 20110127
- International Announcement: WO2011/092253 WO 20110804
- Main IPC: A61K39/04
- IPC: A61K39/04 ; C07K14/35
Abstract:
Modified Rv3616c proteins and their use as medicaments, particularly for the prevention of reactivation of tuberculosis.
Public/Granted literature
- US20120294882A1 MODIFIED TUBERCULOSIS ANTIGENS Public/Granted day:2012-11-22
Information query
